|
1
|
Eismann EA, Lush E and Sephton SE:
Circadian effects in cancer-relevant Psychoneuroendocrine and
immune pathways. Psychoneuroendocrinology. 35:963–976. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zieker D, Jenne I, Koenigsrainer I,
Zdichavsky M, Nieselt K, Buck K, Zieker J, Beckert S, Glatzle J,
Spanagel R, et al: Circadian expression of clock- and tumor
suppressor genes in human oral mucosa. Cell Physiol Biochem.
26:155–166. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hara Y, Onishi Y, Oishi K, Miyazaki K,
Fukamizu A and Ishida N: Molecular characterization of Mybbp1a as a
co-repressor on the Period2 promoter. Nucleic Acids Res.
37:1115–1126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reppert SM and Weaver DR: Coordination of
circadian timing in mammals. Nature. 418:935–941. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schibler U, Ripperger J and Brown SA:
Peripheral circadian oscillators in mammals: Time and food. J Biol
Rhythms. 18:250–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fu L, Pelicano H, Liu J, Huang P and Lee
C: The circadian gene Period2 plays an important role in tumor
suppression and DNA damage response in vivo. Cell. 111:41–50. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rana S and Mahmood S: Circadian rhythm and
its role in malignancy. J Circadian Rhythms. 8:3–17. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Savvidis C and Koutsilieris M: Circadian
rhythm disruption in cancer biology. Mol Med. 18:1249–1260. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mullenders J, Fabius AW, Madiredjo M,
Bernards R and Beijersbergen RL: A large scale shRNA barcode screen
identifies the circadian clock component ARNTL as putative
regulator of the p53 tumor suppressor pathway. PLoS one.
4:e47982009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang TH, Reardon JT, Kemp M and Sancar A:
Circadian oscillation of nucleotide excision repair in mammalian
brain. Proc Natl Acad Sci USA. 106:2864–2867. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ
and Chang JG: Deregulated expression of the PER1, PER2 and PER3
genes in breast cancers. Carcinogenesis. 26:1241–1246. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Viswanathan AN, Hankinson SE and
Schernhammer ES: Night shift work and the risk of endometrial
cancer. Cancer Res. 67:10618–10622. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sack RL, Auckley D, Auger RR, Carskadon
MA, Wright KP Jr, Vitiello MV and Zhdanova IV; American Academy of
Sleep Medicine: Circadian rhythm sleep disorders: Part I, basic
principles, shift work and jet lag disorders. An American Academy
of Sleep Medicine Review. Sleep. 30:1460–1483. 2007.PubMed/NCBI
|
|
14
|
Rengarajan T, Nandakumar N, Rajendran P,
Haribabu L, Nishigaki I and Balasubramanian MP: D-pinitol promotes
apoptosis in MCF-7 cells via induction of p53 and Bax and
inhibition of Bcl-2 and NF-κB. Asian Pac J Cancer Prev.
15:1757–1762. 2014. View Article : Google Scholar
|
|
15
|
Zhu L, Yu J, Zhang W, Xie B and Zhu Y:
Research progress on the central mechanism underlying regulation of
visceral biological rhythm by per2 (Review). Mol Med Rep.
10:2241–2248. 2014.PubMed/NCBI
|
|
16
|
Qu X, Metz RP, Porter WW, Neuendorff N,
Earnest BJ and Earnest DJ: The clock genes period 1 and period 2
mediate diurnal rhythms in dioxin-induced Cyp1A1 expression in the
mouse mammary gland and liver. Toxicol Lett. 196:28–32. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang S, Liu A, Weidenhammer A, Cooksey RC,
McClain D, Kim MK, Aguilera G, Abel ED and Chung JH: The role of
mPer2 clock gene in glucocorticoid and feeding rhythms.
Endocrinology. 150:2153–2160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang
C, Wang X, Wang Z, Cornelissen-Guillaume G and Halberg F: Circadian
gene mPer2 overexpression induces cancer cell apoptosis. Cancer
Sci. 97:589–596. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okabe T, Kumagai M, Nakajima Y, Shirotake
S, Kodaira K, Oyama M, Ueno M and Ikeda M: The impact of HIF1α on
the Per2 circadian rhythm in renal cancer cell lines. PLoS One.
9:e1096932014. View Article : Google Scholar
|
|
20
|
Hsu CM, Lin SF, Lu CT, Lin PM and Yang MY:
Altered expression of circadian clock genes in head and neck
squamous cell carcinoma. Tumour Biol. 33:149–155. 2012. View Article : Google Scholar
|
|
21
|
Lengyel Z, Lovig C, Kommedal S, Keszthelyi
R, Szekeres G, Battyáni Z, Csernus V and Nagy AD: Altered
expression patterns of clock gene mRNAs and clock proteins in human
skin tumors. Tumour Biol. 34:811–819. 2013. View Article : Google Scholar
|
|
22
|
Lin YM, Chang JH, Yeh KT, Yang MY, Liu TC,
Lin SF, Su WW and Chang JG: Disturbance of circadian gene
expression in hepatocellular carcinoma. Mol Carcinog. 47:925–933.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Soták M, Polidarová L, Ergang P, Sumová A
and Pácha J: An association between clock genes and
clock-controlled cell cycle genes in murine colorectal tumors. Int
J Cancer. 132:1032–1041. 2013. View Article : Google Scholar
|
|
24
|
Hu ML, Yeh KT, Lin PM, Hsu CM, Hsiao HH,
Liu YC, Lin HY, Lin SF and Yang MY: Deregulated expression of
circadian clock genes in gastric cancer. BMC Gastroenterol.
14:67–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun CM, Huang SF, Zeng JM, Liu DB, Xiao Q,
Tian WJ, Zhu XD, Huang ZG and Feng WL: Per2 inhibits k562 leukemia
cell growth in vitro and in vivo through cell cycle arrest and
apoptosis induction. Pathol Oncol Res. 16:403–411. 2010. View Article : Google Scholar
|
|
26
|
Murphy PJ and Campbell SS: Physiology of
the circadian system in animals and humans. J Clin Neurophysiol.
13:2–16. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soták M, Sumová A and Pácha J: Cross-talk
between the circadian clock and the cell cycle in cancer. Ann Med.
46:221–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Borgs L, Beukelaers P, Vandenbosch R,
Belachew S, Nguyen L and Malgrange B: Cell 'circadian' cycle: New
role for mammalian core clock genes. Cell Cycle. 8:832–837. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lim S and Kaldis P: Cdks, cyclins and
CKIs: Roles beyond cell cycle regulation. Development.
140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Štorcelová M, Vicián M, Reis R, Zeman M
and Herichová I: Expression of cell cycle regulatory factors hus1,
gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock
gene per2 in human colorectal carcinoma tissue. Mol Biol Rep.
40:6351–6361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gotoh T, Vila-Caballer M, Santos CS, Liu
J, Yang J and Finkielstein CV: The circadian factor Period 2
modulates p53 stability and transcriptional activity in unstressed
cells. Mol Biol Cell. 25:3081–3093. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brennan P, Hainaut P and Boffetta P:
Genetics of lung-cancer susceptibility. Lancet Oncol. 12:399–408.
2011. View Article : Google Scholar
|
|
33
|
Bell LA and Ryan KM: Life and death
decisions by E2F-1. Cell Death Differ. 11:137–142. 2004. View Article : Google Scholar
|
|
34
|
Rivadeneira DB, Mayhew CN, Thangavel C,
Sotillo E, Reed CA, Graña X and Knudsen ES: Proliferative
suppression by CDK4/6 inhibition: Complex function of the
retinoblastoma pathway in liver tissue and hepatoma cells.
Gastroenterology. 138:1920–1930. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang X, Wood PA, Oh EY, Du-Quiton J,
Ansell CM and Hrushesky WJ: Down regulation of circadian clock gene
Period 2 accelerates breast cancer growth by altering its daily
growth rhythm. Breast Cancer Res Treat. 117:423–431. 2009.
View Article : Google Scholar
|
|
37
|
Levine AJ: p53, the cellular gatekeeper
for growth and division. Cell. 88:323–331. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hallstrom TC, Mori S and Nevins JR: An
E2F1-dependent gene expression program that determines the balance
between proliferation and cell death. Cancer Cell. 13:11–22. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin PY, Fosmire SP, Park SH, Park JY,
Baksh S, Modiano JF and Weiss RH: Attenuation of PTEN increases p21
stability and cytosolic localization in kidney cancer cells: A
potential mechanism of apoptosis resistance. Mol Cancer. 6:16–31.
2007. View Article : Google Scholar : PubMed/NCBI
|
